Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06607796
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-18
Brief Title:
Efficacy and Safety of Intratumoral Toluenesulfonamide PTS Injection in Stage IV Driver Gene-Negative NSCLC WithWithout Chemoimmunotherapy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Multicenter Study of the Efficacy and Safety of Intratumoral Injection of Toluenesulfonamide PTS in Combination With or Without First-line Chemoimmunotherapy Based on Standard Treatment for Stage IV Driver Gene-negative Non-small Cell Lung Cancer
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study was to evaluate the efficacy and safety of intratumoral injection of toluenesulfonamidePTS in combination with or without first-line chemoimmunization based on standard treatment for stage IV driver gene-negative non-small cell lung cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None